| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/02/2006 | US7038057 Alkylation, acylation |
| 05/02/2006 | US7038055 Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies |
| 05/02/2006 | US7038051 Imidazonaphthyridines |
| 05/02/2006 | US7038049 Anticancer agents; antitumor agents; apoptosis of breast tumor cells; drug resistance leukemia |
| 05/02/2006 | US7038048 Compositions for treatment of cell proliferation disorders |
| 05/02/2006 | US7038046 Triazine derivatives and their use as sunscreens |
| 05/02/2006 | US7038045 Pyrazolotriazines as kinase inhibitors |
| 05/02/2006 | US7038041 Selective nuclear receptor-targeted systems for delivery of cytotoxins to cancer cells for targeted photodynamic therapy |
| 05/02/2006 | US7038040 Process for preparation of 9, 11-epoxy steroids and intermediates useful therein |
| 05/02/2006 | US7038039 Process for selectively producing 1-phosphorylated sugar derivative anomer and process for producing nucleoside |
| 05/02/2006 | US7038038 Coupling silylated 5-azacytosine to a protected ribofuranose using trimethylsilyl trifluoromethane catalyst; cooling, accumulation by filtration, quenching, solvent extraction |
| 05/02/2006 | US7038029 Vaccination |
| 05/02/2006 | US7038016 Dissolving a stable, activated polyoxyethylene glycol (carboxymethyloxy-end group)(aPEG) in a solvent; filtering the the solution to reduce the bioburden/endotoxin levels; used for the preparation of a PEGylated hemoglobin solution |
| 05/02/2006 | US7037945 replication inhibition of infectious pseudorabies virus particles in a host cell by administering a poly-hydroxylated stilbene, particularly resveratrol, or a derivative thereof |
| 05/02/2006 | US7037944 such as 1-[bis(4-chlorophenyl)methyl]-3-[(3,5-difluorophenyl)(methylsulfonyl)methylene]azetidine |
| 05/02/2006 | US7037943 comprising placing a stimulating substance in the eye between the internal limiting membrane and the retina; free of artificial structures, such as tacks or adhesives; for treatment of retinitis pigmentosa, macular degeneration, and retinal bleeding or traction; biocompatability |
| 05/02/2006 | US7037942 Amide compounds for the potentiation of cholinergic activity |
| 05/02/2006 | US7037941 Alpha-and Beta-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors |
| 05/02/2006 | US7037940 Taxol enhancer compounds |
| 05/02/2006 | US7037939 Compound and derivative of gabapentin |
| 05/02/2006 | US7037938 For therapy of urinary incontinence |
| 05/02/2006 | US7037937 Cytotoxic compounds |
| 05/02/2006 | US7037936 such as (4-({[3-(2',2'-dimethyltetrahydropyran-4'-yl)-4-phenylbutylamino]-methyl}-phenyl)-dimethylamine dihydrochloride, for treating or preventing neoplastic disorders via modulation of ligase activity; renal failure, inflammatory and immune disorders, cardiovascular or infectious diseases |
| 05/02/2006 | US7037935 4-Pyrrolidino-phenyl-benzyl ether derivatives |
| 05/02/2006 | US7037934 Atorvastatin in combination with one or more members selected from a riboflavin derivative, a tocopherol compound, an ascorbic acid derivative, pantethine and taurine. |
| 05/02/2006 | US7037933 Compounds for treatment of cardiac arrhythmia, synthesis, and methods of use |
| 05/02/2006 | US7037932 such as (lepido%3S)-3-(1-Benzothien-7-yloxy)-N-methyl-3-phenyl-1-propanamine oxalate; for treatment of pain |
| 05/02/2006 | US7037931 CCK-1 receptor modulators |
| 05/02/2006 | US7037930 3-arylphenyl sulfide derivative and insecticide and miticide |
| 05/02/2006 | US7037929 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 05/02/2006 | US7037928 Compositions of N-(methylethylaminocarbonyl)-4-(-3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides |
| 05/02/2006 | US7037927 Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor |
| 05/02/2006 | US7037926 Anticarcinogenic, antiallergen, and antiinflammatory agents; autoimmuned diseases |
| 05/02/2006 | US7037925 for treating or preventing organ transplant rejection, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes, asthma, rhinitis, atopic dermatitis, autoimmune disorders, Alzheimer's disease, leukemia |
| 05/02/2006 | US7037924 Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors |
| 05/02/2006 | US7037923 MAP p38 kinase inhibitors; antiarthritic, antiinflammatory, antiischemic, and anticarcinogenic agents; reperfusion injuries; autoimmune and carciovascular diseases |
| 05/02/2006 | US7037922 tachykinin NK-3 receptor antagonists have potential utility in treatment of broad array of disorders and diseases of central nervous system and periphery in mammals in which activation of NK-3 receptors is of importance, such as anxiety, panic disorder, depression, schizophrenia |
| 05/02/2006 | US7037921 Compounds and methods for inhibiting MRP1 |
| 05/02/2006 | US7037920 Substituted tricyclic himbacine derivatives that are useful as thrombin receptor antagonists |
| 05/02/2006 | US7037919 novel nonsteroidal compounds and salts; have a specific and strong binding affinity for androgen receptors and exhibit AR agonism or antagonism; therapeutic effect on AR-mediated diseases such as male hypogonadism, male sexual dysfunction, anemia, aids, breast, prostate cancer |
| 05/02/2006 | US7037918 Antidiabetic agents, cardiovascular disorders, Alzheimer's disease, nervous system disorders |
| 05/02/2006 | US7037917 Nitrogen compounds such as 4-((4-amino-5-bromo-6-(4-cyano-2,6-dimethylphenyloxy)-2 -pyrimidinyl)amino)benzonitrile, used as protease inhibitors for prophylaxis of viral diseases |
| 05/02/2006 | US7037916 Antiinflammatory agents; antiarthritic agents; anticholesterol agents; cardiovascular disorders; muscle and skin disorders |
| 05/02/2006 | US7037915 fused thienopyrimidine compounds useful as phosphatidylinositol 3-kinase inhibitors and carcinostatic agents |
| 05/02/2006 | US7037914 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient |
| 05/02/2006 | US7037913 Piperazinyl derivatives of naphthalenes, (iso)quinolines and naphthyridines; used particularly the treatment of HIV and AIDS. |
| 05/02/2006 | US7037912 Enzyme inhibitor contains two or more ligand moieties comprising pyrimidinyl groups covalently linked together by linking groups; keratitis, diabetic retinopathy, angiogenesis, vision defects, ischemia, atherosclerosis,psoriasis, cancer, cirrhosis, diabetes, arthritis, autoimmune disease |
| 05/02/2006 | US7037911 For thromboembolic disorder from unstable angina, acute coronary syndrome, myocardial infarction, ischemia, stroke, atherosclerosis |
| 05/02/2006 | US7037910 Pyridazino[6,1-c ][1,2,4]triazin-4-ones; mediate physiological and psychotropic effects; antagonists; antiemetics; |
| 05/02/2006 | US7037909 Tetracyclic compounds as c-Met inhibitors |
| 05/02/2006 | US7037908 HIV integrase inhibitors |
| 05/02/2006 | US7037907 Prodrug of an estradiol conjugated to a glucuronide sugar; 6-oxo-2-methoxyestradiol; 3-acetyl-6-oxo-2-methoxyestradiol; and 2-methoxyestradiol-6-hydrazone; angiogenesis inhibitor; antiinflammatory for asthma or rheumatoid arthritis |
| 05/02/2006 | US7037906 Time dependent administration of paclitaxel and combretastatin A-4 phosphate prodrug salt; reduce blood to tumor |
| 05/02/2006 | US7037905 Pharmaceutical use of boronic acids and esters thereof |
| 05/02/2006 | US7037904 Improved appetite and energy level; reduced nausea and vomiting; immunostimulation; sleep and emotional support |
| 05/02/2006 | US7037902 Substituted triazolopyrimidine, pyridazinone, pyridine ordiazolohexahydroquinoline derivatives which bind to the erythropoietin receptor modulatin the domain of the recptor; bioassay |
| 05/02/2006 | US7037901 Treatment of breast cancer; the amount of indolocarbazole derivative is at a non-cytotoxic level, for enhancing radiotherapy; converts tumor DNA topology modifying activity into a DNA breaking poison |
| 05/02/2006 | US7037900 Composition and method for treating graft-versus-host disease |
| 05/02/2006 | US7037899 Derivatives of 2-3-O- isopropylidene- alpha -L-xylo-2-hexulofuranosonic acid, useful for treating inflammatory and autoimmune diseases |
| 05/02/2006 | US7037898 Tumor-activated prodrug compounds and treatment |
| 05/02/2006 | US7037893 Tetrapeptides identify multiple sclerosis antibodies; solid phase synthesis |
| 05/02/2006 | US7037890 For cancer therapy |
| 05/02/2006 | US7037718 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof |
| 05/02/2006 | US7037668 Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616 |
| 05/02/2006 | US7037665 Compositions comprising SNORF36 receptor compounds |
| 05/02/2006 | US7037656 Methods and compositions for identifying ligands for nuclear receptors |
| 05/02/2006 | US7037652 Diagnosing prostate cancer in humans; obtain tissue sample, monitor gene expression, compare to control, evaluate for cancer |
| 05/02/2006 | US7037643 Measurement urinary catalytic iron; therapy for human kidney disease is administering chelate iron; measurement protein, creatinine and blood urea nitrogen in urine |
| 05/02/2006 | US7037534 Inactivation of viral infections agents by chemiluminescence activated light-sensitive compounds |
| 05/02/2006 | US7037530 Mixture containing silica; blending, granulation |
| 05/02/2006 | US7037529 Spraying a suspension of microionized fenofibrate and polyvinylpyrrolidone onto an inert hydrosoluble carrier; immediate-release; improved dissolution |
| 05/02/2006 | US7037528 Microprecipitation method for preparing submicron suspensions |
| 05/02/2006 | US7037527 Bifunctionalized polyester material for surface treatment and biomodification |
| 05/02/2006 | US7037525 Oxacarbazepine film-coated tablets |
| 05/02/2006 | US7037524 Oral delivery of a botanical |
| 05/02/2006 | US7037523 Controlled release compositions for macrolide antimicrobial agents |
| 05/02/2006 | US7037513 Bodywash additives |
| 05/02/2006 | US7037509 Immunologically significant herpes simplex virus antigens and methods for using same |
| 05/02/2006 | US7037495 Antimicrobial compositions |
| 05/02/2006 | US7037490 Apparatus and method for local application of polymeric material to tissue |
| 05/02/2006 | US7037489 Skin external agents and drugs |
| 05/02/2006 | US7037450 Production scale method of forming microparticles |
| 05/02/2006 | US7037377 preparing raw material liquid so that lactulose content within powder produced following spray drying is 10 to 50% by weight, protein content is 0.2 to 9.0 parts by weight per 1 part by weight of lactulose, and chlorine content is no more than 0.08 parts by weight per 1 part by weight of protein, drying |
| 05/02/2006 | CA2401191C A composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer |
| 05/02/2006 | CA2358394C Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 05/02/2006 | CA2354877C Method for the preparation of citalopram |
| 05/02/2006 | CA2334012C 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 05/02/2006 | CA2326804C Compounds with activity on muscarinic receptors |
| 05/02/2006 | CA2250426C Amidinohydrazones as protease inhibitors |
| 05/02/2006 | CA2206005C Aniline derivatives possessing an inhibitory effect of nitric oxide synthase |
| 05/02/2006 | CA2198010C 4-(2-amino-6-(cyclopropylamino)-9h-purin-9-yl)-2-cyclopentene-1-methanol succinate as antiviral agent |
| 05/02/2006 | CA2191843C The preparation of nalbuphine having low levels of beta-epimer |
| 05/02/2006 | CA2184375C Oligonucleotide n3'-p5' phosphoramidates: synthesis and compounds; hybridization and nuclease resistance properties |
| 05/02/2006 | CA2174544C Method for using pharmaceutical compositions containing 2-(2-alkylphenylamino)-oxazolines, 2-(2-alkylphenyl-amino)-thiazolines and 2-(2-alkylphenylamino)-imidazolines as adrenergic agents |
| 05/02/2006 | CA2173974C Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 05/02/2006 | CA2149147C Pharmacologically active pyrimidineamine derivatives and processes for the preparation thereof |
| 05/02/2006 | CA2117939C Ceramides, process for their preparation and their uses in cosmetics and in dermopharmacy |
| 05/02/2006 | CA2061836C Nmda antagonists |
| 04/27/2006 | WO2006045056A2 Flavonoid composition for treating oral diseases |
| 04/27/2006 | WO2006045050A1 Methods and compositions for protecting cells from ultrasound-mediated cytolysis |